These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27832971)

  • 1. Metronomic chemotherapy in head and neck cancer.
    De Felice F; Benevento I; Musella A; Musio D; Tombolini V
    Cancer Lett; 2017 Aug; 400():219-222. PubMed ID: 27832971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Head and neck cancer: metronomic chemotherapy.
    De Felice F; Musio D; Tombolini V
    BMC Cancer; 2015 Oct; 15():677. PubMed ID: 26459302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective randomized phase II study comparing metronomic chemotherapy with chemotherapy (single agent cisplatin), in patients with metastatic, relapsed or inoperable squamous cell carcinoma of head and neck.
    Patil VM; Noronha V; Joshi A; Muddu VK; Dhumal S; Bhosale B; Arya S; Juvekar S; Banavali S; D'Cruz A; Bhattacharjee A; Prabhash K
    Oral Oncol; 2015 Mar; 51(3):279-86. PubMed ID: 25578869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of palliative metronomic chemotherapy in head and neck cancer.
    Patil VM; Noronha V; Joshi A; Nayak L; Pande N; Chandrashekharan A; Dhumal S; Bhattacharjee A; Banavali S; Prabhash K
    Indian J Cancer; 2017; 54(1):25-29. PubMed ID: 29199656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcomes of Head and Neck Cancer Patients Treated with Palliative Oral Metronomic Chemotherapy at a Tertiary Cancer Center in Kerala, India.
    Nv V; Muttath G; Jones J; Shringarpure K; Duraisamy K; Deenathayalan VP; Rathi P
    Gulf J Oncolog; 2020 May; 1(33):68-74. PubMed ID: 32476653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evidence-based medicine (EBM) for radiation therapy--head and neck cancer].
    Sakata K
    Gan To Kagaku Ryoho; 2003 Mar; 30(3):334-8. PubMed ID: 12669389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of metronomic chemotherapy in the treatment of esophageal and gastroesophageal cancer.
    Noronha V; Patil VM; Joshi A; Chougule A; Banavali S; Prabhash K
    Cancer Lett; 2017 Aug; 400():267-275. PubMed ID: 28109908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metronomic low-dose chemotherapy as antiangiogenic therapeutic strategy for cancer.
    Gille J; Spieth K; Kaufmann R
    J Dtsch Dermatol Ges; 2005 Jan; 3(1):26-32. PubMed ID: 16353746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advances in the treatment of head and neck tumors. I. Chemotherapy].
    Stupp R; Vokes EE
    Strahlenther Onkol; 1995 Jan; 171(1):12-7. PubMed ID: 7839300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction chemotherapy decreases the rate of distant metastasis in patients with head and neck squamous cell carcinoma but does not improve survival or locoregional control: a meta-analysis.
    Ma J; Liu Y; Huang XL; Zhang ZY; Myers JN; Neskey DM; Zhong LP
    Oral Oncol; 2012 Nov; 48(11):1076-84. PubMed ID: 22800881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical overview of metronomic chemotherapy in breast cancer.
    Munzone E; Colleoni M
    Nat Rev Clin Oncol; 2015 Nov; 12(11):631-44. PubMed ID: 26241939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of induction chemotherapy for head and neck squamous cell carcinoma.
    Haigentz M; Cohen EE; Wolf GT; Strojan P; Eisbruch A; Ferlito A
    Oral Oncol; 2012 Nov; 48(11):1065-7. PubMed ID: 22981388
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction chemotherapy in head and neck cancer.
    Adelstein DJ
    Hematol Oncol Clin North Am; 1999 Aug; 13(4):689-98, v-vi. PubMed ID: 10494507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral metronomic chemotherapy in recurrent, metastatic and locally advanced head and neck cancers.
    Patil V; Noronha V; Krishna V; Joshi A; Prabhash K
    Clin Oncol (R Coll Radiol); 2013 Jun; 25(6):388. PubMed ID: 23434353
    [No Abstract]   [Full Text] [Related]  

  • 15. Metronomic chemotherapy for cancer treatment: a decade of clinical studies.
    Romiti A; Cox MC; Sarcina I; Di Rocco R; D'Antonio C; Barucca V; Marchetti P
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):13-33. PubMed ID: 23475105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent clinical evidence on metronomic dosing in controlled clinical trials: a systematic literature review.
    Wichmann V; Eigeliene N; Saarenheimo J; Jekunen A
    Acta Oncol; 2020 Jul; 59(7):775-785. PubMed ID: 32275176
    [No Abstract]   [Full Text] [Related]  

  • 17. Pan-European Expert Meeting on the Use of Metronomic Chemotherapy in Advanced Breast Cancer Patients: The PENELOPE Project.
    Cazzaniga ME; Munzone E; Bocci G; Afonso N; Gomez P; Langkjer S; Petru E; Pivot X; Sánchez Rovira P; Wysocki P; Torri V
    Adv Ther; 2019 Feb; 36(2):381-406. PubMed ID: 30565179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standard, and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based review.
    Murdoch D
    Curr Opin Oncol; 2007 May; 19(3):216-21. PubMed ID: 17414639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysphagia in head and neck cancer.
    Manikantan K; Khode S; Sayed SI; Roe J; Nutting CM; Rhys-Evans P; Harrington KJ; Kazi R
    Cancer Treat Rev; 2009 Dec; 35(8):724-32. PubMed ID: 19751966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.